It is the second licensing deal involving siRNA between GSK and a Chinese biotech in the last few months, coming after the UK ...

New findings point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer. In everyday life, when things turn out ...

In everyday life, when things turn out the opposite of what you expect, it's usually cause for frustration. In science, it's often the starting point for discovery. That's what happened to a team of ...

Researchers analyzed small extracellular vesicles (sEVs) from different cell types. Different sEVs delivered siRNA to different therapeutic areas, supporting their role in precise gene-silencing ...

Southeast Asia is quietly emerging as one of the most dynamic frontiers in RNA interference (RNAi) biotechnology, as governments, academic institutions, and pharmaceutical companies converge on a tech ...